Diagnostic performance of central vein sign versus oligoclonal bands for multiple sclerosis
Results suggest similar diagnostic performance of simplified CVS methods and OCB. Ongoing studies will refine whether CVS could be used in replacement or in conjunction with OCB.
Authors
- Daniel Pelletier (ORCID: https://orcid.org/0000-0003-0741-5615)
- Eduardo Caverzasi (ORCID: https://orcid.org/0000-0002-0350-0460)
- Jiwon Oh (ORCID: https://orcid.org/0000-0001-5519-6088)
- Léorah Freeman (ORCID: https://orcid.org/0000-0002-5696-1797)
- Andrew J Solomon (ORCID: https://orcid.org/0000-0003-1602-1554)
- Daniel Ontaneda (ORCID: https://orcid.org/0000-0002-2838-9148)
- Bruce Cree (ORCID: https://orcid.org/0000-0001-7689-2533)
- J. Andrew Derbyshire
- Daniel S. Reich (ORCID: https://orcid.org/0000-0002-2628-4334)
- Praneeta Raza (ORCID: https://orcid.org/0000-0001-6043-3201)
- Erin E. Longbrake (ORCID: https://orcid.org/0000-0002-1179-3937)
- Melissa L. Martin (ORCID: https://orcid.org/0000-0001-8631-5596)
- Russell Taki Shinohara (ORCID: https://orcid.org/0000-0001-8627-8203)
- Lynn Daboul (ORCID: https://orcid.org/0000-0002-2158-3992)
- Christina Azevedo (ORCID: https://orcid.org/0000-0002-8622-1845)
- Matthew K. Schindler (ORCID: https://orcid.org/0000-0003-0157-5669)
- Carly M. O’Donnell (ORCID: https://orcid.org/0000-0003-2730-6758)
- Quy Cao (ORCID: https://orcid.org/0000-0002-6204-1305)
- Karlo Toljan (ORCID: https://orcid.org/0000-0002-3189-9659)
- Elias S. Sotirchos (ORCID: https://orcid.org/0000-0002-8812-1637)
- Peter A. Calabresi (ORCID: https://orcid.org/0000-0002-7776-6472)
- Roland G. Henry (ORCID: https://orcid.org/0000-0002-8232-7562)
- Nancy L. Sicotte (ORCID: https://orcid.org/0000-0002-5131-3352)
- Nico Papinutto (ORCID: https://orcid.org/0000-0003-2184-4782)
- Amit Bar‐Or (ORCID: https://orcid.org/0000-0001-7179-0335)
- Pascal Sati (ORCID: https://orcid.org/0000-0002-6763-0125)
- Rohini Samudralwar
- Paulo Rodrigues (ORCID: https://orcid.org/0000-0002-2102-1746)
Institutions
- University of Vermont (US)
- University of Southern California (US)
- Cedars-Sinai Medical Center (US)
- Brigham and Women's Hospital (US)
- St. Michael's Hospital (CA)
- National Institutes of Health (US)
- Cleveland Clinic (US)
- Johns Hopkins University (US)
- University of California, San Francisco (US)
- University of Toronto (CA)
- University of Pavia (IT)
- Yale University (US)
- Cleveland Clinic Lerner College of Medicine (US)
- National Institute of Neurological Disorders and Stroke (US)
- Penn Center for AIDS Research (US)
- National Institute of Mental Health (US)
- University of Pennsylvania (US)
- The University of Texas at Austin (US)
- The University of Texas Health Science Center at Houston (US)
Publication Details
- Journal
- Multiple Sclerosis Journal
- Published
- 2024-09-01
- DOI
- https://doi.org/10.1177/13524585241271988
- Citations
- 16
- Primary Topic
- Multiple Sclerosis Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 6.80
Funders
- Bristol-Myers Squibb
- Eli Lilly and Company
- AstraZeneca
- GlaxoSmithKline
- Sanofi
- Biogen
- Alexion Pharmaceuticals
- Celgene
- TG Therapeutics
- Race to Erase MS
- Atara Biotherapeutics
- Horizon Therapeutics
- Multiple Sclerosis Society
- Idorsia Pharmaceuticals
- MedDay Pharmaceuticals
- National Institutes of Health
- Genentech
- EMD Serono
- Sanofi Genzyme
- National Institute of Neurological Disorders and Stroke